Heartseed Inc. (TYO:219A)

Japan flag Japan · Delayed Price · Currency is JPY
1,683.00
+49.00 (3.00%)
Jul 31, 2026, 3:30 PM JST
Market Cap38.50B -52.7%
Revenue (ttm)3.03B +777.9%
Net Income592.50M
EPS25.71
Shares Out 22.87M
PE Ratio65.46
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume184,700
Open1,631.00
Previous Close1,634.00
Day's Range1,603.00 - 1,705.00
52-Week Range1,343.00 - 3,925.00
Beta-0.85
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Heartseed

Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. In addition, the company offers differentiation induction, mass culture, purification, and myocardial globule production technology. The company was incorp... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Country Japan
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 219A
Full Company Profile

Financial Performance

Financial Statements